Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review
Journal of Gastrointestinal Cancer · 2025
DOI: 10.1007/s12029-024-01140-5 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Gastrointestinal Cancer, 2025. Verfasst von Rodrigo Gomes Taboada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Medullary, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor response to chemotherapy. High-frequency microsatellite instability (MSI-H) is a rare biological phenomenon in conventional PDAC, being more frequently described in tumors with medullary or mucinous features. METHODS AND RESULTS: In this manuscript, we report the case of a patient with an MSI-H pancreatic carcinoma with medullary features (medullary carcinoma of the pancreas-MCP) that achieved a complete pathological response after neoadjuvant modified FOLFIRINOX. Additionally, we summarize the available evidence on the clinical, pathological, and molecular features of patients with MCP, along with survival outcomes. CONCLUSIONS: MCPs present significant sensitivity not only to immune checkpoint inhibitors, but also to systemic chemotherapy and that the latter treatment modality should not be overlooked. They also present different pathological and molecular features compared with conventional PDAC, meaning they should be considered a separate pathological entity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
- Department of Radiology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
- Department of Clinical and Functional Genomics, International Research Center, AC Camargo Cancer Center, São Paulo, SP, Brazil.
- National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation (INCITO), São Paulo, SP, Brazil.
- Department of Pathology, AC Camargo Cancer Center, São Paulo, SP, Brazil.
- Department of Abdominal Surgical Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Zitieren
APA
Taboada, R. G., Arruda Almeida, M. F., Santiago, K. M., Carraro, D. M., Nunes, W. A., Diniz, A. L., Felismino, T. C., & de Jesus, V. H. F. (2025). Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-024-01140-5
Vancouver
Taboada RG, Arruda Almeida MF, Santiago KM, Carraro DM, Nunes WA, Diniz AL, et al. Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review. Journal of Gastrointestinal Cancer. 2025. doi:10.1007/s12029-024-01140-5
BibTeX
@article{Taboada2025,
author = {Taboada, Rodrigo Gomes and Arruda Almeida, Maria Fernanda and Santiago, Karina Miranda and Carraro, Dirce Maria and Nunes, Warley Abreu and Diniz, Alessandro Landskron and Felismino, Tiago Cordeiro and de Jesus, Victor Hugo Fonseca},
title = {Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review},
journal = {Journal of Gastrointestinal Cancer},
year = {2025},
doi = {10.1007/s12029-024-01140-5}
}
EUVIMED